![]() PeptiDream PeptiDream (ペプチドリーム) is a biopharmaceutical company specializing in drug discovery and development. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ![]() Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | |
Founding Date | Founding Date 2006 | Founding Date 1928 | Founding Date 1935 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Kawasaki, JP HQ Tokyo, JP | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more |
Employees | Employees 736 | Employees 9,052 | Employees 27,764 |
Valuation ($) | Valuation ($) 2.4 b | Valuation ($) 34.3 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥18.5b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) |
Cost of goods | Cost of goods ¥9.2b (FY, 2025) | Cost of goods €1.4b (FY, 2025) | Cost of goods ₹95.5b (FY, 2026) |
Gross profit | Gross profit ¥9.3b (FY, 2025) | Gross profit €7.2b (FY, 2025) | Gross profit ₹195b (FY, 2026) |
Net income | Net income (¥3.7b) (FY, 2025) | Net income €1.6b (FY, 2025) | Net income ₹38.7b (FY, 2026) |

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View company